The story of Viagra, and its developer copyright, presents a complex case study for investors. Initially a blockbuster drug, generating billions in income, its patent expiration created a flood of knock-off https://bookmarkshome.com/story7218997/copyright-s-pill-and-the-pharmaceutical-sector-a-risky-opportunity